1. Home
  2. DAVE vs IRTC Comparison

DAVE vs IRTC Comparison

Compare DAVE & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dave Inc.

DAVE

Dave Inc.

HOLD

Current Price

$348.88

Market Cap

4.8B

Sector

Technology

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

N/A

Current Price

$111.88

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DAVE
IRTC
Founded
2017
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.2B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
DAVE
IRTC
Price
$348.88
$111.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$312.75
$197.92
AVG Volume (30 Days)
327.7K
504.3K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
222.91
61.71
EPS
4.60
N/A
Revenue
$554,182,000.00
$747,138,000.00
Revenue This Year
$26.28
$19.60
Revenue Next Year
$17.38
$15.94
P/E Ratio
$78.67
N/A
Revenue Growth
59.67
26.24
52 Week Low
$152.21
$100.85
52 Week High
$458.25
$210.01

Technical Indicators

Market Signals
Indicator
DAVE
IRTC
Relative Strength Index (RSI) 48.28 39.09
Support Level $330.32 $102.62
Resistance Level $448.24 $127.33
Average True Range (ATR) 20.21 4.99
MACD 1.55 -0.86
Stochastic Oscillator 43.41 2.55

Price Performance

Historical Comparison
DAVE
IRTC

About DAVE Dave Inc.

Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: